DPY30 Sticks a Fork in PDAC Immunity

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with poor response to immunotherapy.
• Replication stress and genome instability can activate anti-tumor immunity via the cGAS/STING pathway.
• Regulators of replication stress may influence immunotherapy outcomes.

Purpose of the Study:

• To identify regulators of replication stress that impact immune activation in PDAC.
• To investigate the role of dumpy-30 (DPY30) in PDAC's immune response and sensitivity to immunotherapy.

Main Methods:

• Investigated the function of DPY30, a component of the WRAD complex and SET1/MLL histone methyltransferases.
• Assessed the impact of DPY30 loss on replication fork protection, DNA damage, and cGAS/STING pathway activation in PDAC.
• Evaluated changes in immune cell infiltration, T cell-mediated killing, and immune checkpoint blockade (ICB) response in DPY30-deficient PDAC models.

Main Results:

• DPY30 loss compromises replication fork protection, leading to DNA damage and robust cGAS/STING activation.
• DPY30-deficient PDAC tumors exhibit increased immune cell infiltration and enhanced sensitivity to T cell-mediated killing.
• Inhibition of DPY30 improves the response to immune checkpoint blockade (ICB) in PDAC.
• DPY30 functions as a replication fork-specific chromatin effector, promoting H3K4 and H3K9 methylation at replication forks.

Conclusions:

• DPY30 acts as a suppressor of replication stress-induced immune activation in PDAC.
• Targeting DPY30 can amplify antitumor immunity and potentiate immunotherapy responses in PDAC.
• DPY30 inhibition offers a potential strategy to overcome resistance to immunotherapy in PDAC and other cancers.